Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT)
暂无分享,去创建一个
G K Crompton | P. Barnes | N. Roche | L. Corbetta | O. Usmani | P. Barnes | M. Broeders | J. Dubus | B. Chawes | F. Lavorini | M. Levy | T. Voshaar | P. Dekhuijzen | G. Crompton | W Vincken | J. Sanchís | J Sanchis | P J Barnes | Omar S Usmani | J. Viejo | W. Vincken | S. Pedersen | T. Hausen | J C Dubus | F Lavorini | Soren Pedersen | Mark L Levy | P N R Dekhuijzen | M Broeders | C J Corrigan | B L Chawes | L Corbetta | Th Hausen | N Roche | J Viejo | Th Voshaar | C. Corrigan | N. Roche
[1] M. Everard,et al. Factors affecting total and "respirable" dose delivered by a salbutamol metered dose inhaler. , 1995, Thorax.
[2] C. Vogelmeier,et al. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma , 2007, Current medical research and opinion.
[3] Prevention of exercise induced asthma by inhaled salmeterol xinafoate. , 1992, Archives of disease in childhood.
[5] T. Battelino,et al. Influence of anti-asthmatic medications on dental caries in children in Slovenia. , 2013, International journal of paediatric dentistry.
[6] S. Pedersen,et al. Fenoterol powder inhaler technique in children: influence of inspiratory flow rate and breath-holding. , 1986, European journal of respiratory diseases.
[7] Gerald C. Smaldone,et al. Drug Delivery to the Lung , 2001 .
[8] J. L. Rau,et al. The importance of nonelectrostatic materials in holding chambers for delivery of hydrofluoroalkane albuterol. , 2006, Respiratory care.
[9] P. Jones,et al. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal , 2010, Thorax.
[10] S. Newman. Spacer Devices for Metered Dose Inhalers , 2004, Clinical pharmacokinetics.
[11] P. Barry,et al. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. , 1995, British journal of clinical pharmacology.
[12] J. Donohue,et al. Accuracy of float testing for metered-dose inhaler canisters. , 2002, Journal of the American Pharmaceutical Association.
[13] M. Newhouse,et al. Optimal delivery of aerosols from metered dose inhalers. , 1981, Chest.
[14] G. Crompton,et al. Comparison of Pulmicort pMDI plus Nebuhaler and Pulmicort Turbuhaler in asthmatic patients with dysphonia. , 2000, Respiratory medicine.
[15] Marco Lodi,et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. , 2011, Respiratory medicine.
[16] M Kaila,et al. A 10 year asthma programme in Finland: major change for the better , 2006, Thorax.
[17] D. Postma,et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex , 2005, Thorax.
[18] J. Oppenheimer,et al. The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devices. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[19] Satisfacción y preferencia del paciente asmático por los dispositivos de inhalación. Aplicación del FSI-10 , 2008 .
[20] B. Monz,et al. Development and Validation of a Patient Satisfaction and Preference Questionnaire for Inhalation Devices , 2005, Treatments in respiratory medicine.
[21] G. Crompton,et al. Beclomethasone dipropionate aerosol and oropharyngeal candidiasis. , 1976, British journal of diseases of the chest.
[22] L. Borgström,et al. Lung deposition of budesonide in asthmatics: a comparison of different formulations , 1998 .
[23] L. Borgström,et al. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. , 1998, The European respiratory journal.
[24] J. Dubus,et al. Electrostatic charge on spacer devices and salbutamol response in young children. , 2003, International journal of pharmaceutics.
[25] C. Rand,et al. Noncompliance and treatment failure in children with asthma. , 1996, The Journal of allergy and clinical immunology.
[26] G K Crompton,et al. Problems patients have using pressurized aerosol inhalers. , 1982, European journal of respiratory diseases. Supplement.
[27] R. D. de Haan,et al. Predictors of incorrect inhalation technique in patients with asthma or COPD: a study using a validated videotaped scoring method. , 2010, Journal of aerosol medicine and pulmonary drug delivery.
[28] J. J. Klein,et al. Multiple inhalers confuse asthma patients. , 1999, The European respiratory journal.
[29] Hak-Kim Chan,et al. The role of particle properties in pharmaceutical powder inhalation formulations. , 2002, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[30] E. Wu,et al. Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers , 2011, Journal of medical economics.
[31] G. Crompton,et al. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. , 2000, Respiratory medicine.
[32] J. J. Klein,et al. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.
[33] G. Waterer,et al. Reducing electrostatic charge on spacer devices and bronchodilator response. , 2000, British journal of clinical pharmacology.
[34] S. Julious,et al. Assessing fullness of asthma patients' aerosol inhalers. , 1994, The British journal of general practice : the journal of the Royal College of General Practitioners.
[35] A. Weinstein. When should your asthmatic patients refill their MDI propelled with chlorofluorocarbons? , 1998, Delaware medical journal.
[36] P. Anderson,et al. Importance of inhaler-device satisfaction in asthma treatment: Real-world observations of physician-observed compliance and clinical/patient-reported outcomes , 2011, Advances in therapy.
[37] E. McKnight,et al. Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the Global Initiative for Asthma (GINA) strategy: a retrospective analysis , 2013, Primary care respiratory journal : journal of the General Practice Airways Group.
[38] H. Kotaki,et al. [Effects of mouth wash on the removing beclomethasone dipropionate delivered by pressurized aerosol metered-dose inhaler in the mouth]. , 1999, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[39] R. Horne. Compliance, adherence, and concordance: implications for asthma treatment. , 2006, Chest.
[40] B. Chipps,et al. Dose counting and the use of pressurized metered-dose inhalers: running on empty. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[41] G. Rachelefsky,et al. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[42] J. Learmonth. The Doctor's Mission , 1930, The Lancet.
[43] D. Williams,et al. Problems in assessing contents of metered dose inhalers. , 1993, BMJ.
[44] H. Chan,et al. Influence of Humidity on the Electrostatic Charge and Aerosol Performance of Dry Powder Inhaler Carrier based Systems , 2007, Pharmaceutical Research.
[45] D. Pavia,et al. Simple Instructions for using Pressurized Aerosol Bronchodilators1 , 1980, Journal of the Royal Society of Medicine.
[46] R Horne,et al. Compliance in asthma. , 1999, Respiratory medicine.
[47] J. Mitchell,et al. Do we always need computed tomography to detect and treat parapneumonic pleural effusion? , 2012, European Respiratory Journal.
[48] Richard B. Reilly,et al. An Acoustic-Based Method to Detect and Quantify the Effect of Exhalation into a Dry Powder Inhaler. , 2015, Journal of aerosol medicine and pulmonary drug delivery.
[49] S. Colman,et al. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy. , 2007, The American journal of medicine.
[50] Victor C. Strasburger,et al. Review and Recommendations , 1983 .
[51] A. Smith,et al. Childhood asthma and dental erosion. , 2000, ASDC journal of dentistry for children.
[52] J. Thompson,et al. A multicentre comparison of the efficacy of terbutaline Turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. , 1994, The European respiratory journal.
[53] T. Iga,et al. Kinetic analysis of effects of mouth washing on removal of drug residues following inhalation of fluticasone propionate dry powder. , 2007, Biological & pharmaceutical bulletin.
[54] M. Burns,et al. Case-Control Study , 2020, Definitions.
[55] S. Larsson,et al. Clinical consequences of inadequate inhalation technique in asthma therapy. , 1987, European journal of respiratory diseases.
[56] W. Hop,et al. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. , 1999, The European respiratory journal.
[57] J A Anderson,et al. Adherence to inhaled therapy, mortality and hospital admission in COPD , 2009, Thorax.
[58] M. Molimard. How to achieve good compliance and adherence with inhalation therapy , 2005, Current medical research and opinion.
[59] H. Okamoto,et al. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. , 2004, Chemical & pharmaceutical bulletin.
[60] F. Allaert,et al. Improved asthma control with breath-actuated pressurized metered dose inhaler (pMDI): the SYSTER survey. , 2009, European review for medical and pharmacological sciences.
[61] S. Bosnic-Anticevich,et al. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. , 2007, The Journal of allergy and clinical immunology.
[62] Monika Chmielewska,et al. Dysphonia associated with the use of inhaled corticosteroids , 2015, Current opinion in otolaryngology & head and neck surgery.
[63] Absence of gargling affects topical adverse symptoms caused by inhaled corticosteroids in females , 2014, The Journal of asthma : official journal of the Association for the Care of Asthma.
[64] H. Chan,et al. Effect of Relative Humidity on the Electrostatic Charge Properties of Dry Powder Inhaler Aerosols , 2008, Pharmaceutical Research.
[65] J. Toogood,et al. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. , 1980, The Journal of allergy and clinical immunology.
[66] H. Okamoto,et al. Effect of surface layering time of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate. , 2004, Chemical & pharmaceutical bulletin.
[67] S. Newman,et al. The effect of handling techniques on electrostatic charge on spacer devices : a correlation with in vitro particle size analysis , 1996 .
[68] B. Meakin,et al. Effect of exposure to humidity on terbutaline delivery from turbuhaler dry power inhalation devices. , 1993, The European respiratory journal.
[69] S. Pedersen. Optimal use of tube spacer aerosols in asthmatic children , 1985, Clinical allergy.
[70] E. Dağlı,et al. Inhaler medicament effects on saliva and plaque pH in asthmatic children. , 1998, The Journal of clinical pediatric dentistry.
[71] K Colón,et al. Running on empty. , 1996, Minnesota medicine.
[72] Iman A Basheti,et al. Checklists for Powder Inhaler Technique: A Review and Recommendations , 2014, Respiratory Care.
[73] A. Lippman. Adherence to medication. , 2005, The New England journal of medicine.
[74] J. Fonseca,et al. Inhaler devices in asthma and COPD--an assessment of inhaler technique and patient preferences. , 2014, Respiratory medicine.
[75] Virendra Singh,et al. Evaluation of cariogenic potential of dry powder inhalers: A case-control study , 2013, Lung India : official organ of Indian Chest Society.
[76] D. Pavia,et al. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. , 1982, European journal of respiratory diseases. Supplement.
[77] H. Chrystyn,et al. Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung. , 1993, Thorax.
[78] B. Rubin,et al. How do patients determine that their metered-dose inhaler is empty? , 2004, Chest.
[79] [Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire]. , 2008, Archivos de bronconeumologia.
[80] N Roche,et al. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability , 2002, European Respiratory Journal.
[81] L. Borgström,et al. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. , 2005, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[82] P. Daley-Yates,et al. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. , 2001, British journal of clinical pharmacology.
[83] G. Colice,et al. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. , 2007, The New England journal of medicine.
[84] J. L. Rau,et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. , 2005, Chest.
[85] S. Pedersen,et al. How to use a rotahaler. , 1986, Archives of disease in childhood.
[86] Christine C Johnson,et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. , 2004, The Journal of allergy and clinical immunology.
[87] A. Burls. Critical appraisal , 2016, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[88] M. Newhouse,et al. Response of asthmatic patients to fenoterol inhalation: A method of quantifying the airway bronchodilator dose , 1978, Clinical pharmacology and therapeutics.
[89] J. Oppenheimer. Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines , 2006 .
[90] C. Vogelmeier,et al. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. , 2008, Current medical research and opinion.
[91] P. Royall,et al. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers. , 2014, International journal of pharmaceutics.
[92] Jolyon P Mitchell,et al. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.
[93] Robert N. Stavins,et al. ENVIRONMENTAL REGULATION IN THE 1990 S : A RETROSPECTIVE ANALYSIS , 2003 .
[94] J. Shuster,et al. Lung bioavailability of hydrofluoroalkane fluticasone in young children when delivered by an antistatic chamber/mask. , 2006, The Journal of pediatrics.
[95] J. Vestbo,et al. Inhaled corticosteroids and decline of lung function in community residents with asthma , 2006, Thorax.
[96] P. Lawford,et al. Pressurized bronchodilator aerosol technique: influence of breath-holding time and relationship of inhaler to the mouth. , 1982, British journal of diseases of the chest.
[97] T. Ueda,et al. Repeated Instruction on Inhalation Technique Improves Adherence to the Therapeutic Regimen in Asthma , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.
[98] M. Metintaş,et al. Oropharyngeal candidiasis with dry-powdered fluticasone propionate: 500 μg/day versus 200 μg/day , 2008 .
[99] T. L. Rogers,et al. Investigation of Some Commercially Available Spacer Devices for the Delivery of Glucocorticoid Steroids from a pMDI , 2001, Drug development and industrial pharmacy.
[100] R. Simon,et al. How patients determine when to replace their metered-dose inhalers. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.